Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF

NCT00144989 is registered in ClinicalTrials.gov with Haruhiko Fukuda as lead sponsor.

NCT NCT00144989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF
Lead sponsor
Haruhiko Fukuda
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2002
Completion date
September 30, 2011
Enrollment
281 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

small-cell-lung cancer